Clinical Trial Update: Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Phase 3]

View source ↗

Summary

Phase 3 study results update for bosentan in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-12-31